Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection

- Rosenthal, Philip, Schwarz, Kathleen B., Brainard, Diana M., Hsueh, Chia-Hsiang, Shao, Jiang, Parhy, Bandita, Davison, Suzanne, Feiterna-Sperling, Cornelia, Gillis, Lynette A., Indolfi, Giuseppe, Sokal, Etienne M., Murray, Karen F., Gonzalez-Peralta, Regino P., Wirth, Stefan, Lin, Chuan-Hao, Kelly, Deidre A., Nightingale, Scott, Balistreri, William F., Bansal, Sanjay, Jonas, Maureen M., Massetto, Benedetta

Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens

- Milliken, Eliza, De Zwart, Auke E. S., Alffenaar, Jan-Willem C., Marriott, Deborah J. E., Riezebos-Brilman, Annelies, Schteinman, Ana, Evans, Allan M., Glanville, Allan R., Verschuuren, Erik A. M., Reuter, Stephanie E.

Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective

- Tran, Huy A., Jones, Tracey L., Ianna, Elizabeth A., Foy, Aidan, Reeves, Glenn E. M.

Thyroid disease in chronic hepatitis C Infection and interferon-α based therapy

- Tran, Huy A.

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study

- Tran, Huy A., Jones, Tracey L., Ianna, Elizabeth A., Reeves, Glenn E. M.

Peginterferon and ribavirin for hepatitis C (letter)

- Duggan, Anne E., Duggan, John M.